United States Healthcare Sector Insider Trading Activity

Track insider buying and selling in United States Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 2,075 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.0tn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (371.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mega (358.7bn) -1–5 -$100K–$1M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (237.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (232.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (197.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (185.9bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (162.7bn) 1–5 $1M–$10M 0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (151.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (137.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (132.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (132.1bn) 0 No activity — 0–15%
Healthcare Services Large (131.4bn) 0 No activity — 0–15%
Healthcare Services Large (111.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (105.6bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Large (92.5bn) 0 No activity — 15–50%
Healthcare Services Large (90.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (84.8bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Healthcare Services Large (74.8bn) 0 No activity — 0–15%
Healthcare Services Large (69.3bn) 1–5 $1M–$10M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (60.7bn) 1–5 -$1M–$10M -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (60.2bn) 0 No activity — 0–15%
Healthcare Services Large (52.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US Humana Inc (HUM)
Healthcare Services Large (48.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (46.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (45.8bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (44.0bn) -6–10 -$10M–$100M -0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
Healthcare Services Large (42.3bn) -1–5 -< $100K -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (40.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (40.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (39.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (38.3bn) 0 No activity — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (34.0bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (33.4bn) 0 No activity — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (33.4bn) 0 No activity — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (31.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (31.9bn) 0 No activity — 0–15%
Healthcare Services Large (31.9bn) 0 No activity — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (30.6bn) 0 No activity — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (27.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (27.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (26.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (26.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (25.2bn) -6–10 -$100M+ -0–15% 15–50%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
Healthcare Services Large (23.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (22.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (21.7bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.7bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Healthcare Services Large (18.9bn) 0 No activity — 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.6bn) 0 No activity — 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (17.1bn) -6–10 -$10M–$100M -0–15% 15–50%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (15.7bn) 0 No activity — 0–15%
Healthcare Services Large (15.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (15.6bn) 0 No activity — 0–15%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (14.5bn) 0 No activity — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (14.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (13.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.3bn) 0 No activity — 0–15%
US Penumbra Inc (PEN)
Healthcare Services Large (12.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.4bn) 0 No activity — 0–15%
Healthcare Services Large (12.4bn) 0 No activity — 0–15%
Healthcare Services Large (12.2bn) 0 No activity — 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 No activity — 0–15%
Healthcare Services Large (11.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (11.7bn) 0 No activity — 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 0–15%
Healthcare Services Large (11.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.4bn) -6–10 -$10M–$100M -0–15% 15–50%
US DaVita Inc (DVA)
Healthcare Services Large (11.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (11.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (11.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (10.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.3bn) 0 No activity — 0–15%